Rob L. Mcmurray

Hatfield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study.

Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study.

Journal: Epilepsy research
Published: December 08, 2023

Bioavailability of vitamin D biofortified pork meat: results of an acute human crossover study in healthy adults.

Bioavailability of vitamin D biofortified pork meat: results of an acute human crossover study in healthy adults.

Journal: International journal of food sciences and nutrition
Published: February 27, 2023

Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practice.

Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practice.

Journal: Epilepsia
Published: January 24, 2023

Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT study.

Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT study.

Journal: Frontiers in neurology
Published: December 09, 2022

Improving vitamin D content in pork meat by UVB biofortification.

Improving vitamin D content in pork meat by UVB biofortification.

Journal: Meat science
Published: October 03, 2022

Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study.

Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study.

Journal: Seizure
Published: April 07, 2022

PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice.

PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice.

Journal: Journal of neurology
Published: June 08, 2021

Predictors of seizure freedom, response and retention after 12 months of treatment with eslicarbazepine acetate: A post-hoc analysis of the Euro-Esli study.

Predictors of seizure freedom, response and retention after 12 months of treatment with eslicarbazepine acetate: A post-hoc analysis of the Euro-Esli study.

Journal: Epilepsy research
Published: November 19, 2020

Antibacterial Activity of Four Plant Extracts Extracted from Traditional Chinese Medicinal Plants against Listeria monocytogenes, Escherichia coli, and Salmonella enterica subsp. enterica serovar Enteritidis.

Antibacterial Activity of Four Plant Extracts Extracted from Traditional Chinese Medicinal Plants against Listeria monocytogenes, Escherichia coli, and Salmonella enterica subsp. enterica serovar Enteritidis.

Journal: Microorganisms
Published: June 10, 2020

Eslicarbazepine acetate in post-stroke epilepsy: Clinical practice evidence from Euro-Esli.

Eslicarbazepine acetate in post-stroke epilepsy: Clinical practice evidence from Euro-Esli.

Journal: Acta neurologica Scandinavica
Published: May 11, 2020

Safety, tolerability and effectiveness of transition to eslicarbazepine acetate from carbamazepine or oxcarbazepine in clinical practice.

Safety, tolerability and effectiveness of transition to eslicarbazepine acetate from carbamazepine or oxcarbazepine in clinical practice.

Journal: Seizure
Published: November 15, 2019

Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study.

Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study.

Journal: Neurology and therapy
Published: March 29, 2019
Showing 1-12 of 23

Last Updated: 09/26/2026